Senate HELP Committee Hearing Focuses on 340B Program

Mar 15, 2018 - 03:04 PM
340B pic

The Senate Health, Education, Labor and Pensions Committee today held a hearing to examine the 340B drug savings program. HELP Committee Chairman Lamar Alexander (R-TN) said the purpose of the hearing was to learn more about the program and how it “might be improved so that hospitals and clinics can continue to provide low-income patients with help to afford their health care.” Congress created the 340B program 25 years ago to give eligible health care providers financial relief from high prescription drug costs; however, some stakeholders have urged lawmakers to scale back the program. “Skyrocketing drug prices are a dire problem, and they deserve our urgent attention and serious solutions,” said HELP Committee Ranking Member Patty Murray (D-WA). “Needless to say, rolling back rules to prevent overcharging from drug companies and cutting back programs that help make drugs more affordable is not going to get the job done.” At the hearing, Sen. Bill Cassidy (R-LA) and others expressed concerns about the 340B program. Cassidy has introduced legislation that would make expansive changes to the 340B program, such as implementing a two-year moratorium on certain new 340B hospitals and hospital outpatient departments that could lead to narrower eligibility criteria for hospital outpatient sites and adding new hospital reporting requirements. Sen. Maggie Hassan (D-NH) said, “The place we most need transparency is in drug pricing,” saying that she wished stakeholders like the Pharmaceutical Research and Manufacturers of America advocated as strongly for transparency in the pricing of their own members’ products as they have advocated for transparency in 340B. “There’s no transparency in their pricing so they get away with hiking up prices to reap profits without being held accountable all while everyday Americans struggle with drug prices.” In a statement submitted for the hearing, AHA highlighted how hospitals are using savings from the 340B program to provide access to critical services to their communities. The AHA this week ran an ad in Politico urging Congress to protect 340B and highlighting a recent study that found tax-exempt hospitals in the 340B program provided $51.7 billion in total benefits to their communities in 2015.

Related News Articles

Headline
Court rules that companies may not impose 340B rebate model without HHS approval
The U.S. District Court for the District of Columbia July 21 upheld a lower court’s decision that Section 340B of the Public Health Service Act does not …
Headline
AHA challenges HRSA’s burden estimate for proposed 340B rebate model
The AHA July 14 urged the Health Resources and Services Administration to revise its estimate of the administrative burden associated with the agency’s…
Headline
AHA urges court to reject AbbVie bid to change 340B program rules
The AHA today filed a friend-of-the-court brief supporting the Department of Health and Human Services’ motion to dismiss AbbVie’s lawsuit …
Headline
HRSA announces 340B program sales reached $100 billion in CY 2025
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Keeping Patient Access Front and Center in Washington
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
CMS proposes increases to Medicare hospital outpatient department payment rates, site-neutral and 340B changes
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…